Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf Herman Fridman

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Glycobiology|July 30, 2002
N-glycosylation profile of recombinant human soluble Fcgamma receptor IIINoriko Takahashi, Joel Cohen-Solal, Annie Galinha, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Springer Seminars in Immunopathology|November 11, 2006
Fc gamma receptors and cancerLydie Cassard, Joël Cohen-Solal, Sophie Camilleri-Broët, et al.
Bulletin Du Cancer|November 12, 2003
[Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy]Fabrice Benchetrit, Agnès Gazagne, Olivier Adotevi, et al.
Scientific Reports|February 11, 2018
Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serumHirokazu Yagi, Daisuke Takakura, Lubka T Roumenina, et al.
The Lancet. Oncology|June 30, 2022
How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' replyYann-Alexandre Vano, Réza Elaidi, Letuan Phan, et al.
Immunological Reviews|April 19, 2016
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancersMarie-Caroline Dieu-Nosjean, Nicolas A Giraldo, Hélène Kaplon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytesBeatrix Kotlan, Peter Simsa, Jean-Luc Teillaud, et al.
Frontiers in Immunology|February 6, 2024
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapiesSarah Soussan, Guilhem Pupier, Isabelle Cremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Activation of human peripheral IgM+ B cells is transiently inhibited by BCR-independent aggregation of Fc gammaRIIBEmilie M Fournier, Sophie Sibéril, Anne Costes, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Glycobiology|July 30, 2002
N-glycosylation profile of recombinant human soluble Fcgamma receptor IIINoriko Takahashi, Joel Cohen-Solal, Annie Galinha, et al.
Journal of Leukocyte Biology|August 23, 2008
A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent functionCharles-Antoine Dutertre, Emmanuelle Bonnin-Gélizé, Karen Pulford, et al.
Springer Seminars in Immunopathology|November 11, 2006
Fc gamma receptors and cancerLydie Cassard, Joël Cohen-Solal, Sophie Camilleri-Broët, et al.
Bulletin Du Cancer|November 12, 2003
[Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy]Fabrice Benchetrit, Agnès Gazagne, Olivier Adotevi, et al.
Scientific Reports|February 11, 2018
Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serumHirokazu Yagi, Daisuke Takakura, Lubka T Roumenina, et al.
The Lancet. Oncology|June 30, 2022
How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' replyYann-Alexandre Vano, Réza Elaidi, Letuan Phan, et al.
Immunological Reviews|April 19, 2016
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancersMarie-Caroline Dieu-Nosjean, Nicolas A Giraldo, Hélène Kaplon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytesBeatrix Kotlan, Peter Simsa, Jean-Luc Teillaud, et al.
Frontiers in Immunology|February 6, 2024
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapiesSarah Soussan, Guilhem Pupier, Isabelle Cremer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Activation of human peripheral IgM+ B cells is transiently inhibited by BCR-independent aggregation of Fc gammaRIIBEmilie M Fournier, Sophie Sibéril, Anne Costes, et al.
Pageof 12